Biodexa Pharmaceuticals PLCNASDAQ:BDRX
- LAST PRICE3.4000
- TODAY'S CHANGE (%)-0.4700 (-12.1447%)
- Bid / Lots3.3500/ 1
- Ask / Lots3.4100/ 3
- Open / Previous Close3.8400 / 3.8700
- Day Range
- 52 Week Range
- Volume190,226
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BDRX |
|---|---|---|
| 09:32 ET | 723 | 3.84 |
| 09:35 ET | 2500 | 3.7335 |
| 09:39 ET | 600 | 3.8446 |
| 09:51 ET | 500 | 3.8081 |
| 09:53 ET | 500 | 3.88 |
| 09:55 ET | 700 | 3.78 |
| 10:00 ET | 198 | 3.76 |
| 10:02 ET | 4000 | 3.8 |
| 10:04 ET | 4301 | 3.81 |
| 10:06 ET | 100 | 3.83 |
| 10:08 ET | 5400 | 3.81 |
| 10:13 ET | 1100 | 3.7401 |
| 10:15 ET | 3252 | 3.7 |
| 10:20 ET | 3221 | 3.7 |
| 10:22 ET | 500 | 3.6928 |
| 10:24 ET | 5370 | 3.655 |
| 10:26 ET | 100 | 3.655 |
| 10:27 ET | 10324 | 3.64 |
| 10:29 ET | 3350 | 3.66 |
| 10:31 ET | 1673 | 3.66 |
| 10:33 ET | 100 | 3.635 |
| 10:40 ET | 750 | 3.61 |
| 10:42 ET | 1778 | 3.62 |
| 10:47 ET | 200 | 3.63 |
| 10:49 ET | 500 | 3.63 |
| 10:51 ET | 463 | 3.63 |
| 10:54 ET | 1200 | 3.6301 |
| 10:56 ET | 20688 | 3.6051 |
| 11:00 ET | 1000 | 3.6047 |
| 11:07 ET | 6345 | 3.78 |
| 11:14 ET | 100 | 3.68 |
| 11:16 ET | 3000 | 3.67 |
| 11:36 ET | 100 | 3.65 |
| 11:48 ET | 100 | 3.6601 |
| 11:56 ET | 1493 | 3.69 |
| 11:59 ET | 401 | 3.682 |
| 12:15 ET | 727 | 3.66 |
| 12:17 ET | 100 | 3.69 |
| 12:24 ET | 8349 | 3.56 |
| 12:30 ET | 300 | 3.6113 |
| 12:32 ET | 100 | 3.57 |
| 12:33 ET | 243 | 3.62 |
| 12:44 ET | 1400 | 3.54 |
| 12:46 ET | 1280 | 3.52 |
| 12:48 ET | 1097 | 3.56 |
| 12:50 ET | 1618 | 3.56 |
| 12:55 ET | 13142 | 3.495 |
| 01:00 ET | 2500 | 3.5016 |
| 01:02 ET | 530 | 3.46 |
| 01:04 ET | 625 | 3.48 |
| 01:06 ET | 1403 | 3.45 |
| 01:08 ET | 1032 | 3.4025 |
| 01:09 ET | 100 | 3.4 |
| 01:15 ET | 3091 | 3.45 |
| 01:20 ET | 724 | 3.4844 |
| 01:22 ET | 1841 | 3.45 |
| 01:24 ET | 100 | 3.42 |
| 01:26 ET | 2656 | 3.41 |
| 01:27 ET | 1454 | 3.45 |
| 01:31 ET | 334 | 3.45 |
| 01:33 ET | 858 | 3.47 |
| 01:38 ET | 1000 | 3.45 |
| 01:40 ET | 865 | 3.43 |
| 01:42 ET | 10905 | 3.4499 |
| 01:47 ET | 100 | 3.45 |
| 01:54 ET | 200 | 3.43 |
| 01:56 ET | 500 | 3.43 |
| 02:00 ET | 267 | 3.43 |
| 02:02 ET | 1474 | 3.41 |
| 02:03 ET | 400 | 3.4268 |
| 02:07 ET | 1000 | 3.43 |
| 02:09 ET | 100 | 3.42 |
| 02:14 ET | 2407 | 3.434 |
| 02:16 ET | 100 | 3.385 |
| 02:18 ET | 3852 | 3.3516 |
| 02:20 ET | 701 | 3.37 |
| 02:21 ET | 1100 | 3.34 |
| 02:23 ET | 300 | 3.34 |
| 02:25 ET | 1137 | 3.407 |
| 02:39 ET | 551 | 3.385 |
| 02:43 ET | 100 | 3.37 |
| 02:45 ET | 699 | 3.35 |
| 02:48 ET | 100 | 3.3843 |
| 02:52 ET | 300 | 3.39 |
| 02:57 ET | 1200 | 3.43 |
| 02:59 ET | 2000 | 3.44 |
| 03:03 ET | 300 | 3.43 |
| 03:10 ET | 100 | 3.42 |
| 03:12 ET | 111 | 3.4482 |
| 03:14 ET | 1500 | 3.43 |
| 03:15 ET | 1500 | 3.4 |
| 03:21 ET | 700 | 3.4198 |
| 03:24 ET | 650 | 3.4181 |
| 03:26 ET | 1999 | 3.4199 |
| 03:30 ET | 300 | 3.4136 |
| 03:32 ET | 1000 | 3.42 |
| 03:42 ET | 100 | 3.4 |
| 03:44 ET | 419 | 3.4 |
| 03:50 ET | 100 | 3.4 |
| 03:53 ET | 503 | 3.4 |
| 03:55 ET | 300 | 3.41 |
| 03:57 ET | 1629 | 3.4 |
| 04:00 ET | 1781 | 3.4 |
Nov 29, 2023
Thinking about buying stock in Biomea Fusion, Tuya Inc, Bitfarms, Netflix, or Biodexa Pharmaceuticals?, from 9:31AM ET on Wednesday Nov 29, 2023 by Dow Jones
9:31AM ET on Wednesday Nov 29, 2023 by Dow Jones
Nov 27, 2023
DJ Biodexa Pharma Shares Double After Licensing Deal for Tolimidone, from 10:07AM ET on Monday Nov 27, 2023 by Dow Jones
10:07AM ET on Monday Nov 27, 2023 by Dow JonesDJ Biodexa Enters Worldwide Licensing Deal for Tolimidone, from 9:42AM ET on Monday Nov 27, 2023 by Dow Jones
9:42AM ET on Monday Nov 27, 2023 by Dow JonesBiodexa Enters Into Agreements to Acquire Exclusive Worldwide License to Tolimidone, a Phase II Ready Asset for Type 1 Diabetes, from 9:00AM ET on Monday Nov 27, 2023 by Dow Jones
9:00AM ET on Monday Nov 27, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biodexa Pharmaceuticals PLC | 4.4M | 0.0x | --- |
Finch Therapeutics Group Inc | 6.4M | -0.1x | --- |
Cyclerion Therapeutics Inc | 5.6M | -0.3x | --- |
Xenetic Biosciences Inc | 5.4M | -1.4x | --- |
Soligenix Inc | 7.6M | -0.3x | --- |
Intelligent Bio Solutions Inc | 2.8M | 0.0x | --- |
Company Information
Biodexa Pharmaceuticals PLC is a United Kingdom-based drug delivery technology company. The Company is focused on improving the bio-delivery and bio-distribution of medicines. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. Biodexa Pharmaceuticals Q-Sphera technology focuses on long acting injectables using proprietary 3D printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics. MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility at biological potential of Hydrogen (pH) extending available routes of administration, including direct-to-tumor delivery. It has a pipeline of approximately eight earlier stage programs, MTX110 (Brain Cancer in Children (DIPG)), MTX110 (Medulloblastoma), MTX110 (Glioblastoma), MTX114 (Psoriasis), MTD211 (Schizophrenia, MDD) and others.
Contact Information
- Headquarters
- 1 Caspian Point, Caspian WayABINGDON, United Kingdom CF10 4DQ
- Phone
- 123-584-1575
- Fax
- ---
Executives
- Non-Executive Chairman of the Board
- Stephen Parker
- Chief Executive Officer, Chief Financial Officer, Executive Director, Secretary
- Stephen Stamp
- Chief Scientific Officer
- Dmitry Zamoryakhin
- Vice President - Translational Medicine
- Kelly Conlon
- Vice President - Technology
- Daniel Palmer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.4M |
|---|---|
Revenue (TTM) | $883.0K |
Shares Outstanding | 236.6K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.83 |
EPS | $-62,579.04 |
Book Value | $23,596.16 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 5.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,277.83% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
